Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis

Inclusion Criteria: * Male/Female aged 6-13 years of age * Diagnosis of SAR/PAR, with symptoms within the past 3 months * Positive skin test to inhalant allergen with negative saline control * No previous use of intranasal inhaled, oral, IV or topical steroid use within past 6 months. * If the subject has asthma, only mild intermittent (per NAPP) guidelines treated with PRN bronchodilator Exclusion Criteria: * screening height outside the 5th and 95th percentiles * History of abnormal growth * Any other chronic condition beside allergic rhinitis or mild intermittent asthma * Subject who has insufficient allergic rhinitis symptoms to require daily therapy during the trial. * Subject with a known hypersensitivity to any active ingredients or excipents in the study medications * Subject with nasal candidiasis, acute or chronic sinusitis, significant nasal polyposis (impairs nasal breathing), or other gross anatomical deformity of the nose sufficient to impair nasal breathing (e.g., deviated septum) * Subjects with a history of substance abuse, mental illness or retardation * Subjects with a history or presence of glaucoma or posterior subcapsular cataract * Subjects with nocturnal enuresis. * Use of Theophylline, Intal/Tilade or leukotriene modifiers.